Overview of the micro fluidic diagnostics commercial landscape

Abstract

Since its birth in the late 1980s, the fi eld of micro fluidics has continued to mature, with a growing number of companies pursuing diagnostic applications. In 2009 the worldwide in vitro diagnostics market was estimated at >40 billion USD, And Micro Fluidic Diagnostics Are Poised to Reap A Signi Fi Cant Part of This Mkt. Across A Range of Areas Including Lab. Diagnostics, Point-of-care Diagnostics, Cancer Diagnostics, and Others. the Potential Economic Advantages of Micro Fluidics Are Numerous and Compelling: Lower Reagent And/or Sample Vols., Lower Equip. Costs, Improved Portability, Increased Automat., and Increased Msrmt. Speed. All of These Factors May Help Put More Info. in the Hands of Doctors and Patients Sooner, Enabling Earlier Dis. Detection and More Tailored, Effective Treatments. This Chapter Reviews the Micro Fluidic Diagnostics Comml. Landscape and Discusses Potential Commercialization Challenges and Opportunities. © Springer Sci.+Bus. Media, LLC 2013.